Pontillo G, Prados F, Wink AM, Kanber B, Bisecco A, Broeders TAA, Brunetti A, Cagol A, Calabrese M, Castellaro M, Cocozza S, Colato E, Collorone S, Cortese R, De Stefano N, Douw L, Enzinger C, Filippi M, Foster MA, Gallo A, Gonzalez-Escamilla G, Granziera C, Groppa S, Harbo HF, Høgestøl EAet al.(2025) More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis Hum Brain Mapp, 46(1), e70107 DOI 10.1002/hbm.70107, PubMed 39740239
Rød BE, Høgestøl EA, Torkildsen Ø, Bjørnevik K, Gran JM, Øverås MH, König M, Myhr KM, Wergeland S, Nygaard GO(2025) Comparative effectiveness of rituximab and cladribine in relapsing-remitting multiple sclerosis: A target trial emulation Mult Scler, 31(8), 975-984 DOI 10.1177/13524585251342727, PubMed 40415655
Skattebøl L, Lundby R, Øverås MH, Sowa P, Celius EG, Harbo HF, Nordhøy W, Høgestøl EA, Nygaard GO(2025) Quantitative susceptibility mapping of paramagnetic rim lesions in early multiple sclerosis: A cross-sectional study of brain age and disability Neuroimage Rep, 5(3), 100277 DOI 10.1016/j.ynirp.2025.100277, PubMed 41050950
